Kyowa Kirin Co., Ltd. (TYO:4151)
Japan · Delayed Price · Currency is JPY 2,632.00
-1.00 (-0.04%)
Aug 18, 2025, 3:30 PM JST
Kyowa Kirin Employees
Kyowa Kirin had 5,669 employees as of December 31, 2024. The number of employees decreased by 305 or -5.11% compared to the previous year.
Employees
5,669
Change (1Y)
-305
Growth (1Y)
-5.11%
Revenue / Employee
87.01M JPY
Profits / Employee
6.78M JPY
Market Cap
1,377.83B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,669 | -305 | -5.11% |
| Dec 31, 2023 | 5,974 | 222 | 3.86% |
| Dec 31, 2021 | 5,752 | 329 | 6.07% |
| Dec 31, 2020 | 5,423 | 156 | 2.96% |
| Dec 31, 2019 | 5,267 | -1,975 | -27.27% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chugai Pharmaceutical | 5,026 |
| Takeda Pharmaceutical Company | 47,455 |
| Daiichi Sankyo Company | 19,765 |
| HOYA Corporation | 37,909 |
| Otsuka Holdings | 35,338 |
| Astellas Pharma | 13,643 |
| Shionogi & | 4,955 |
| Olympus | 29,297 |
Kyowa Kirin News
- 16 days ago - Kyowa Kirin Co., Ltd. (KYKOF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress - PRNewsWire
- 4 months ago - 35-YEAR INDUSTRY-ACADEMIC PARTNERSHIP YIELDING GROUNDBREAKING ADVANCES FOR SCIENCE AND PATIENTS RENEWS FOR ANOTHER THREE YEARS BETWEEN LA JOLLA INSTITUTE FOR IMMUNOLOGY AND KYOWA KIRIN - PRNewsWire
- 5 months ago - Amgen Inc (AMGN) and Kyowa Kirin Announce Promising Phase 3 Results for Rocatinlimab in Atopic ... - GuruFocus
- 6 months ago - Kyowa Kirin Announces Late-Breaking Abstract Presentation at the American Academy of Dermatology Annual Meeting 2025 - PRNewsWire
- 6 months ago - Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies - Benzinga
- 7 months ago - Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe - Business Wire
- 7 months ago - AlphaMeld Corporation Expands Collaboration with Kyowa Kirin for Enterprise-Wide Access to Drug Discovery Platform - GlobeNewsWire